Director Stephen B. Burke defers JPM (NYSE: JPM) board retainer into stock grant
Rhea-AI Filing Summary
JPMorgan Chase & Co. director Stephen B. Burke reported a routine equity compensation transaction. He received 171.8449 shares of common stock on June 30, 2026 at $327.3300 per share as a grant or other acquisition, reflecting deferral of his quarterly director retainer into stock.
Following this award, he directly holds 208,303.1020 shares of common stock and indirectly holds 55,245 shares through a GRAT. The filing shows no open-market purchases or sales, only compensation-related and holding entries.
Positive
- None.
Negative
- None.
Insights
Routine director fee deferral into JPMorgan stock, no open-market trading.
Director Stephen B. Burke received 171.8449 JPMorgan common shares at $327.3300 per share as a grant or other acquisition. A footnote explains this reflects deferral of his quarterly retainer, payable in stock after his board service ends.
This is standard board compensation, not an open-market buy or sell, so it carries weak signaling value about his short-term view of the shares. After this transaction, he directly owns 208,303.1020 shares and indirectly 55,245 shares via a GRAT, indicating a substantial continuing equity stake.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 171.845 | $327.33 | $56K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- [object Object]
Key Figures
Key Terms
GRAT financial
quarterly retainer financial
grant, award, or other acquisition financial
FAQ
What did JPM director Stephen B. Burke report in this Form 4 for JPM?
Stephen B. Burke reported receiving 171.8449 JPMorgan common shares as a grant or other acquisition. The award reflects deferral of his quarterly director retainer into stock, rather than an open-market purchase or sale, making it routine compensation-related activity.
Was the JPM Form 4 filing for Stephen B. Burke a stock buy or sell?
The filing does not show any open-market buys or sells by Stephen B. Burke. It records a grant or other acquisition of 171.8449 common shares tied to deferred director fees, along with a separate holding entry for shares owned indirectly through a GRAT.
What price is associated with Stephen B. Burke’s JPM stock grant on June 30, 2026?
The grant to Stephen B. Burke is recorded at a price of $327.3300 per JPMorgan common share. This price is used for the 171.8449-share award that represents deferral of his quarterly retainer into stock-based compensation.
What does the GRAT reference mean in Stephen B. Burke’s JPM holdings?
The filing shows 55,245 JPMorgan shares held indirectly “By GRAT,” referring to a grantor retained annuity trust. This entity holds shares associated with Burke, separate from his 208,303.1020 directly owned shares reported after the June 30, 2026 transaction.